Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Obesity is a serious chronic disease affecting millions of Californians, including our most vulnerable communities on Medi-Cal. It's directly linked to over 230 other serious diseases, results in over 500,000 deaths annually, and is the second greatest predictor of death and hospitalizations after age.
In the last several years, the development and deployment of anti-obesity medications has proven to be a lifesaver in the fight against this disease. They're effective and safe medications that lead to significant weight loss and offer several other benefits, including reduced blood pressure, improved sleep apnea, and improved glycemic health, all of which help to lower long-term healthcare costs. Recent studies have shown that they reduce the risk of cardiovascular disease, our nation's leading cause of death, by 20%.
The effectiveness of anti-obesity medications in reducing these obesity-related conditions have helped to lower long-term healthcare costs. Their use over the next decade could save the country more than $175 billion in healthcare costs thanks to reduced hospitalizations and treatment of other diseases.
Medi-Cal patients have been fortunate enough to have access to these powerful medications for the last few years. And thanks to the creation of Medi-Cal Rx by Governor Newsom and drug prices negotiations under the program, California has access to affordable medication that improves the lives and health of millions and they can continue to provide them to all Medi-Cal enrollees that need them.